review of glp 1 GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing kidney failure. Adverse events are mostly gastrointestinal. Read GLP-1 therapy appears to reduce
Description
Consulte siempre con su mdico si nota algo inusual
The treatment often includes I.V
But before we go down that path, one of the other things that has come out is that GLP-1s do seem to have other knock-on effects beyond weight loss and beyond diabetes, and so can you talk a little bit about some of the potential of GLP-1s for other health conditions
This fueled an exponential growth in interest among the public, but not everyone qualifies for GLP-1s through their insurance or can afford them, even if they do
At the same time, nearly everyone who comes in for weight loss surgery has already tried a GLP-1
